We previously showed that G9a-deficient cells form smaller tumors compared to wild-type controls and the use of the G9A inhibitor BIX-01294 reduced tumor formation, suggesting that G9A inhibition may have anti-tumorigenic effects [6]. The gene discussed is EHMT2; the disease is neoplasm.